Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 28 , ISSUE S2 ( August, 2024 ) > List of Articles

GUIDELINES

ISCCM Position Statement: Management of Severe Dengue in Intensive Care Unit

Ashish Bhalla, Harpreet Singh, Vikas Suri, Lakshminarayana Yaddanapudi, Banani Poddar, Ravi Ghawat, R Natesh Prabu, Tapas Kumar Sahoo, Chacko Jose, Ashit Hegde, Khusrav Bajan, Vinod Kumar Singh, Diptimala Agarwal

Keywords : Critically ill patients, Dengue, Intensive care unit

Citation Information :

DOI: 10.5005/jp-journals-10071-24748

License: CC BY-NC 4.0

Published Online: 10-08-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Dengue is one of the commonest causes of undifferentiated acute febrile illness in India as well as South East Asia. Nearly two-fifths of the world population is at risk of infection, and nearly 96 million infections reported worldwide, it is a major cause of concern across the globe. The ISCCM leadership felt that there have been no new directives/guidelines except the MOH guidelines for the management of dengue fever since 2014. Under the auspices of the Indian Society of Critical Care Medicine (ISCCM), an expert group of 14 intensivists from across the country, was formed. The task force members formulated questions that needed to be answered. These questions were validated by the members of ISCCM attending research conclave 2023. All the members systematically searched PubMed, MEDLINE, and Science Direct for original articles on different aspects of dengue management between January 1, 2000, and July 1, 2023. From the collected articles, duplicates were removed. Based on the evidence collected, the expert group members prepared statements/answers to the questions. Since most of the evidence is of moderate to low quality, a consensus was generated amongst the members of the task force. Each statement was agreed upon by 70% of the task force. The statements presented in the article are consensus statements as answers to queries raised.

HTML PDF Share
  1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature 2013;496(7446):504–507. DOI: 10.1038/nature12060.
  2. Chen LH, Wilson ME. Transmission of dengue virus without a mosquito vector: Nosocomial mucocutaneous transmission and other routes of transmission. Clin Infect Dis 2004;39(6):e56–e60. DOI: 10.1086/423807.
  3. Amancio FF, Heringer TP, de Oliveira Cda C, Fassy LB, de Carvalho FB, Oliveira DP, et al. Clinical profiles and factors associated with death in adults with dengue admitted to intensive care units, Minas Gerais, Brazil. PLoS One 2015;10(6):e0129046. DOI: 10.1371/journal.pone.0129046.
  4. Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 2005;3(1):13–22. DOI: 10.1038/nrmicro1067.
  5. Sahaphong S, Riengrojpitak S, Bhamarapravati N, Chirachariyavej T. Electron microscopic study of the vascular endothelial cell in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1980;11(2):194–204. PMID: 7434071.
  6. World Health Organization. Dengue: Guidelines for diagnosis, treatment, prevention and control, New edition. WHO: Geneva. 2009. Available from: http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf?ua=1.
  7. Srikiatkhachorn A, Green S. Markers of dengue disease severity. Curr Top Microbiol Immunol 2010;338:67–82. DOI: 10.1007/978-3-642-02215-9_6.
  8. Srichaikul T, Nimmanitaya S, Artchararit N, Siriasawakul T, Sungpeuk P. Fibrinogen metabolism and disseminated intravascular coagulation in dengue hemorrhagic fever. Am J Trop Med Hyg 1977;26(3):525–532. DOI: 10.4269/ajtmh.1977.26.525.
  9. National guidelines for clinical management of Dengue. MOH guidelines India. 2014. Available from: https://ncvbdc.mohfw.gov.in/WriteReadData/l892s/Dengue-National-Guidelines-2014.pdf.
  10. Kumarasamy V, Wahab AHA, Chua SK, Hassan Z, Chem YK, Mohamad M, et al. Evaluation of a commercial dengue NS1 antigen-capture ELISA for laboratory diagnosis of acute dengue virus infection. J Virol Methods 2007;140:75–79. DOI: 10.1016/j.jviromet.2006.11.001.
  11. Dussart P, Petit L, Labeau B, Bremand L, Leduc A, Moua D, et al. Evaluation of two new commercial tests for the diagnosis of acute dengue virus infection using NS1 antigen detection in human serum. PLoS Negl Trop Dis 2008;2(8):e280. DOI: 10.1371/journal.pntd.0000280.
  12. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, et al. Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody. PLoS Negl Trop Dis 2014;8(10):e3171. DOI: 10.1371/journal.pntd.0003171.
  13. A-Nuegoonpipat A, Panthuyosri N, Anantapreecha S, Chanama S, Sa-Ngasang A, Sawanpanyalert P, et al. Cross-reactive IgM responses in patients with dengue or Japanese encephalitis. J Clin Virol 2008;42(1):75–77. DOI: 10.1016/j.jcv.2007.10.030.
  14. Changal KH, Raina AH, Raina A, Raina M, Bashir R, Latief M, et al. Differentiating secondary from primary dengue using IgG to IgM ratio in early dengue: An observational hospital based clinico-serological study from North India. BMC Infect Dis 2016;16(1):715. DOI: 10.1186/s12879-016-2053-6.
  15. GOI guidelines for admission in intensive care units. Available from: https://dghs.gov.in/Uploaddata/Final%20Guidelines%20for%20ICU%20Admission%20and%20Discharge%20Criteria%2023.12.2023.pdf.
  16. Kattan E, Hernández G. The role of peripheral perfusion markers and lactate in septic shock resuscitation. J Intensive Med 2021;2(1):17–21. DOI: 10.1016/j.jointm.2021.11.002.
  17. Giang HT, Banno K, Minh LH, Trinh LT, Loc LT, Eltobgy A, et al. Dengue hemophagocytic syndrome: A systematic review and meta-analysis on epidemiology, clinical signs, outcomes, and risk factors. Rev Med Virol 2018;28(6):e2005. DOI: 10.1002/rmv.2005.
  18. Rawat N, Sahni N, Yaddanapudi L. Comparison of commercially available balanced salt solution and ringer's lactate on extent of correction of metabolic acidosis in critically ill patients. Indian J Crit Care Med 2020;24(7):539–543. DOI: 10.5005/jp-journals-10071- 23488.
  19. Zhou S, Zeng Z, Wei H, Sha T, An S. Early combination of albumin with crystalloids administration might be beneficial for the survival of septic patients: A retrospective analysis from MIMIC-IV database. Ann Intensive Care 2021;11(1):42. DOI: 10.1186/s13613-021-00 830-8.
  20. Georger JF, Hamzaoui O, Chaari A, Maizel J, Richard C, Teboul JL. Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients. Intensive Care Med 2010;36(11):1882–1889. DOI: 10.1007/s00134-010-2013-3.
  21. Khan Assir MZ, Kamran U, Ahmad HI, Bashir S, Mansoor H, Anees SB, et al. Effectiveness of platelet transfusion in dengue Fever: A randomized controlled trial. Transfus Med Hemother 2013;40(5):362–368. DOI: 10.1159/000354837.
  22. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol 2003;122(1):10–23. DOI: 10.1046/j.1365-2141.2003.04468.x.
  23. Kaur P, Kaur G. Transfusion support in patients with dengue fever. Int J Appl Basic Med Res 2014;4(Suppl 1):S8–S12. DOI: 10.4103/2229-516X.140708.
  24. Vlaar AP, Oczkowski S, de Bruin S, Wijnberge M, Antonelli M, Aubron C, et al. Transfusion strategies in non-bleeding critically ill adults: A clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med 2020;46(4):673–696. DOI: 10.1007/s00134-019-05884-8.
  25. Dimaano EM, Saito M, Honda S, Miranda EA, Alonzo MT, Valerio MD, et al. Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection. Am J Trop Med Hyg 2007;77(6):1135–1138. DOI: 10.4269/ajtmh.2007.77.1135.
  26. Zhang F, Kramer CV. Corticosteroids for treating dengue shock syndrome. Cochrane Database Syst Rev 2014;(7):CD003488. DOI: 10.1002/14651858.CD003488.pub3.
  27. Chakraborty S, Alam S, Sayem M, Sanyal M, Das T, Saha P, et al. Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients – A phase II randomized controlled clinical trial. E Clinical Medicine 2020;29–30:100624. DOI: 10.1016/j.eclinm.2020.100624.
  28. Kumarasena RS, Mananjala Senanayake S, Sivaraman K, de Silva AP, Dassanayake AS, Premaratna R, et al. Intravenous N-acetylcysteine in dengue-associated acute liver failure. Hepatol Int 2010;4(2):533–534. DOI: 10.1007/s12072-010-9176-4.
  29. Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, et al. Guidelines on the use of therapeutic aphaeresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The sixth special issue. J Clin Apher 2013;28(3):145–284. DOI: 10.1002/jca. 21276.
  30. AICOG guidelines for management of Dengue in Pregnancy. 2014. Available from: http://www. ACOG+guidelines+dengue+2014.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.